Fluorobiotech is proud to share that the company and its co-founders, Dr. Du Preez van Staden and Dr. Ross Rayne Vermeulen, were recently profiled by the Stellenbosch Network as part of their prestigious Entrepreneur of the Month series. The feature highlights Fluorobiotech’s inspiring journey from academic research to biotechnology entrepreneurship,...
Fluorobiotech Celebrates CQO Etienne du Toit’s Completion of ISO 13485:2016 Lead Auditor Training
Fluorobiotech is proud to congratulate our Chief Quality Officer, Etienne du Toit, on the successful completion of the CQI and IRCA Certified Medical Devices – Quality Management Systems Auditor/Lead Auditor Training Course (ISO 13485:2016) (PR369). This prestigious certification highlights Etienne’s unwavering commitment to quality, compliance, and continuous improvement — values...
Fluorobiotech Celebrates National Science Week: Honouring South African Innovation and Scientific Excellence
Fluorobiotech proudly joins the national celebration of National Science Week in South Africa - a time to reflect on the transformative role of science and technology in shaping a healthier, more sustainable future. As a biotechnology company rooted in innovation, Fluorobiotech recognizes that science is more than a discipline, it...
Fluorobiotech CEO Shares Startup Insights at AUDA-NEPAD Home Grown Solutions Masterclass
Fluorobiotech CEO, Dr. Du Preez van Staden, was recently invited to speak at the AUDA-NEPAD Home Grown Solutions (HGS) Masterclass, a high-impact learning session designed to empower African entrepreneurs in the health and biotech sectors. The event brought together early-stage innovators and startup founders from across the continent, offering practical...
Fluorobiotech Joins Global Dialogue at Connect Cities: London x Cape Town Tech Summit
Fluorobiotech was proud to attend the recent Connect Cities: London x Cape Town Tech Summit, hosted by Grow London Global and London & Partners, which brought together innovators, entrepreneurs, and government leaders from two of the world’s leading tech hubs. The summit served as a platform for deepening collaboration between...
Celebrating RNA: The Unsung Hero of Molecular Biology 🧬
August 1st marked RNA Day, a moment to celebrate one of science’s most elegant and essential molecules. While DNA often steals the spotlight, it's RNA that rolls up its sleeves and gets to work — transcribing, translating, and even starring in next-generation vaccines. At Fluorobiotech, where mRNA and its molecular...
Fluorobiotech’s Mission: Decentralizing Enzyme Manufacturing for a More Equitable Biotech Future
Fluorobiotech is on a mission to redefine access to essential biotechnology infrastructure by transforming how critical enzymes are produced, supplied, and scaled. With a focus on innovation, affordability, and autonomy, the company is empowering underserved markets and industries through next-generation recombinant protein technologies that decentralize enzyme manufacturing and build lasting...
Fluorobiotech Showcases Local Biomanufacturing Innovation at WHO / MPP Global Partners Meeting
Fluorobiotech was honored to present at the Global Partners Meeting of the WHO / Medicines Patent Pool (MPP) mRNA Vaccine Technology Transfer Program, a landmark event that brought together manufacturers, policymakers, and researchers from over 15 countries committed to building mRNA vaccine manufacturing capacity in low- and middle-income countries (LMICs)....
Fluorobiotech Takes the African Tech Stage at VivaTech 2025 in Paris
Fluorobiotech proudly represented African innovation on the global stage as Chief Operating Officer, Dr. Ross Rayne Vermeulen delivered a pitch at VivaTech 2025, one of the world’s leading events for technology and innovation. Selected to present on the African Tech Stage, Vermeulen shared Fluorobiotech’s ambitious mission to transform Africa into...
Fluorobiotech Selected as Finalist in AUDA-NEPAD ‘Home Grown Solutions’ Accelerator for Pandemic Resilience
Fluorobiotech is proud to announce its selection as a finalist in the prestigious 5th Cohort of the AUDA-NEPAD ‘Home Grown Solutions’ Accelerator for Pandemic Resilience. The program, which aims to strengthen Africa’s ability to respond to pandemics by supporting high-impact health innovations, received more than 200 written applications from 37...